CSL Ltd Annual Report 2020

Expanding our R&D footprint Pasadena, California, US Expanding CSL Behring’s R&D facility in Pasadena, California, US. This will enable us to focus on cell and gene therapy that promises to advance our new capabilities in this scientific platform. Marburg, Germany Construction of CSL Behring’s R&D campus in Marburg, Germany. Scheduled for completion in 2022. CSL’s new global headquarters in the Parkville Biomedical Precinct in Melbourne, Australia. Scheduled for completion in 2024, the facility will house around 800 employees. CSL Limited Annual Report 2020 22